Key result
Edoxaban showed no significant difference in the incidence of hemorrhagic events compared to warfarin in patients with severe motor and intellectual disabilities and deep vein thrombosis.
Why the study?
Patients with severe motor and intellectual disabilities frequently develop paralysis and have high sudden death rates potentially caused by pulmonary thromboembolism, drawing attention to deep vein thrombosis as an embolic source.
Does edoxaban improve efficacy and safety compared to warfarin in patients with severe motor and intellectual disabilities and deep vein thrombosis?
RCT (n=11)
Open-label
Block randomization
Yes
Does edoxaban improve efficacy and safety compared to warfarin in patients with severe motor and intellectual disabilities and deep vein thrombosis?
Answers are grounded in this paper and cite their sources.
Comparable bleeding may support edoxaban as alternative; leaves open efficacy and randomized confirmation in this population.
Objective: Patients with severe motor and intellectual disabilities (SMID) often develop complications, including paralysis of the extremities due to abnormal muscular tonicity. Furthermore, the incidence of sudden death, which may be caused by pulmonary thromboembolism (PTE), is approximately 4.2%. Deep vein thrombosis (DVT) is attracting attention as an embolic source. In this study, DVT was confirmed in SMID patients by lower extremity venous ultrasound. The oral anticoagulant, warfarin, and novel oral anticoagulant, edoxaban tosilate hydrate, were administered, and their efficacies and safeties were evaluated.
No takes yet. Share an insight, caveat, or question.
Ohmori et al. (2019) conducted an RCT in Deep vein thrombosis in severe motor and intellectual disabilities (n=11). Edoxaban vs. Warfarin was evaluated on Incidence of hemorrhagic events (major bleeding and clinically important bleeding) (p=0.5383). Edoxaban showed no significant difference in the incidence of hemorrhagic events compared to warfarin in patients with severe motor and intellectual disabilities and deep vein thrombosis.
Synapse has enriched 10 related papers. Consider them for comparative context: